Pharming (PHAR) Current Taxes (2023 - 2024)
Pharming (PHAR) posted Current Taxes of $72.4 million for Q1 2024, down 4.86% on a QoQ basis from $76.1 million in Q4 2023.
Pharming (PHAR) Current Taxes (2023 - 2024) Analysis & Trends
Pharming's Current Taxes history runs 2 years deep, the most recent figure standing at $72.4 million for Q1 2024.
- Quarterly Current Taxes changed N/A year-over-year to $72.4 million in Q1 2024, while the trailing twelve-month figure through Mar 2024 was $72.4 million (changed N/A YoY) and the FY2023 annual result came in at $76.1 million, changed N/A from the prior year.
- Current Taxes was $72.4 million for Q1 2024 at Pharming, down from $76.1 million in the prior quarter.
- Across five years, Current Taxes topped out at $76.1 million in Q4 2023 and bottomed at $72.4 million in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 63.52 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 49.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Pharming | 9.02 Bn | 8.96 Bn | 65.80 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 72.40 Mn |
| Dec 31, 2023 | 76.10 Mn |